10272MARCHOpen (affiliates only)Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Subjects with Progressive Familial Intrahepatic CholestasisMRX-502NCT03905330IndustryChildrenTreatmentIIINationalOtherEkong, UdemeGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC PFS; GUMC Pediatrics; GUMC Transplant; GUMC Transplant - Liver2021R3.1 Build 22 <a href="https://advarra.com" target="_blank">© 2024 Advarra, Inc.</a>